BioSpace News Archive

Biotech Bay

CytomX Therapeutics Announces New Employment Inducement Grants - Aug 17, 2021

CytomX Therapeutics, Inc. announced that on August 16, 2021, the Company granted seven new employees options to purchase a total of 172,600 shares of the Company’s common stock at an exercise price per share equal to $4.81, which was the closing trading price on August 16, 2021, the date of the grant.

August 17, 2021
·
2 min read
Smith+Nephew expands its leading WEREWOLF™ Technology into total joint arthroplasty with launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand

Smith+Nephew, the global medical technology business, announces the launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading radio-frequency technology to orthopaedic reconstruction surgeons.

August 17, 2021
·
6 min read
Aequus and reVision to Collaborate on Stargardt Disease Program

Aequus Pharmaceuticals Inc. and reVision Therapeutics, Inc. announce a collaboration on the development of a therapy for Stargardt disease.

August 17, 2021
·
7 min read
Business

Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment

Shorla Pharma today announced a partnership to support the launch and commercialization of Shorla’s oncology portfolio.

August 17, 2021
·
3 min read
Business

Intrance Medical Systems Names Krai Chatamra, Ph.D., Vice President of Clinical Development

Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, announced the appointment of Krai Chatamra, Ph.D., to Vice President of Clinical Development.

August 17, 2021
·
3 min read
Business

CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021.

August 17, 2021
·
5 min read
Business

Alzamend Neuro Announces It Has Contracted With Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer’s Disease in September 2021

Alzamend Neuro, Inc. today announced that it contracted Altasciences to conduct a six-month Phase I relative bioavailability study for AL001 for dementia related to Alzheimer’s disease in September 2021.

August 17, 2021
·
5 min read
Business

Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update

Tenax Therapeutics, Inc. today reported financial results for the second quarter of 2021 and provided a business update.

August 17, 2021
·
9 min read
BioForest

Aptevo Therapeutics Announces APVO436 Monotherapy is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Aptevo Therapeutics Inc. today announced the publication of a peer-reviewed research article in the prestigious oncology journal Cancers.

August 17, 2021
·
8 min read
Business

Arthrosi Establishes Joint Venture in China to Accelerate Development of Innovative Drug Portfolio

Arthrosi Therapeutics, Inc. today announced a joint venture in Guangzhou, China with Guangzhou Ruiao Biopharmaceutical Technology Co., Ltd. (“a subsidiary of ApicHope Phamaceutical”) to form Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd.

August 17, 2021
·
2 min read